METABOLIC AND CARDIOVASCULAR RISKS OF SECOND-GENERATION ANTIPSYCHOTICS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF WEIGHT GAIN, DYSLIPIDEMIA, HYPERGLYCEMIA, AND QTC PROLONGATION IN ADULTS WITH SCHIZOPHRENIA OR BIPOLAR DISORDER COMPARING OLANZAPINE, RISPERIDONE, QUETIAPINE, AND ARIPIPRAZOLE. Frontier in Medical and Health Research, [S. l.], v. 4, n. 3, p. 599–610, 2026. Disponível em: https://fmhr.net/index.php/fmhr/article/view/2481.. Acesso em: 4 aug. 2026.